Summary

During this program, you will help develop new analytical methods for late phase drug substances and drug products. The Scientist will work closely with a team of analytical chemists and organic chemists, responsible for the technical aspects of developing the analytical tools to gain understanding of key quality attributes in product and process for late phase synthetic programs. The scientist will be involved in advancing our capabilities in automated software solutions (integrating AI and predictive modelling) that help streamline data interpretation. This project will enable development of robust data packages for submission to agencies to advance therapies through our Amgen pipeline. You will help make data more consumable and accessible through automated software improvements and other digital tools.

Job description

What You Will Do

During this program, you will help develop new analytical methods for late phase drug substances and drug products. The Scientist will work closely with a team of analytical chemists and organic chemists, responsible for the technical aspects of developing the analytical tools to gain understanding of key quality attributes in product and process for late phase synthetic programs. The scientist will be involved in advancing our capabilities in automated software solutions (integrating AI and predictive modelling) that help streamline data interpretation. This project will enable development of robust data packages for submission to agencies to advance therapies through our Amgen pipeline. You will help make data more consumable and accessible through automated software improvements and other digital tools.

Program Eligibility Requirements

Expected completion of one year of study from an accredited college or university prior to the internship commencing
Expected continued enrollment in an accredited college or university following the internship program
Student must be located in the United States for the duration of the internship program
Must be available to work a full-time schedule.

Basic Qualifications

18 years or older
Currently enrolled in a full-time Bachelor’s Degree program from an accredited college or university with a 3.0 minimum GPA or equivalent

Preferred Qualifications

Degree concentration(s) in Chemistry, Pharmaceutical Sciences or related fields
Hands-on Chemistry Lab experience and passion
Chromatography and Spectrometry Knowledge and Theoretical Understanding
Synthetic/Organic Chemistry Knowledge
Python/MATLAB and AI/machine-learning familiarity
Basic biochemistry/peptide knowledge

Requirements

18 years or older
Currently enrolled in a full-time Bachelor’s Degree program from an accredited college or university with a 3.0 minimum GPA or equivalent
Expected completion of one year of study from an accredited college or university prior to the internship commencing
Expected continued enrollment in an accredited college or university following the internship program
Student must be located in the United States for the duration of the internship program
Must be available to work a full-time schedule
Degree concentration(s) in Chemistry, Pharmaceutical Sciences or related fields
Hands-on Chemistry Lab experience and passion
Chromatography and Spectrometry Knowledge and Theoretical Understanding
Synthetic/Organic Chemistry Knowledge
Python/MATLAB and AI/machine-learning familiarity
Basic biochemistry/peptide knowledge

Benefits

Networking events
Community volunteer projects
Professional growth support

Company overview

Amgen Inc. is a leading American multinational biopharmaceutical company headquartered in Thousand Oaks, California, founded in 1980. As one of the world's largest independent biotechnology companies, Amgen specializes in discovering, developing, manufacturing, and delivering innovative human therapeutics. The company focuses on six key therapeutic areas: inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience. Amgen's portfolio includes blockbuster drugs such as Enbrel for autoimmune diseases, Prolia and XGEVA for osteoporosis, Repatha for cholesterol management, Otezla for psoriasis, and Neulasta for chemotherapy-induced neutropenia. With approximately 28,000 employees worldwide, Amgen operates as a component of both the Dow Jones Industrial Average and Nasdaq-100 indices. The company maintains a robust research and development pipeline with numerous clinical programs across various stages, leveraging cutting-edge biotechnology and human genetic data to address some of the world's most challenging diseases. Amgen's manufacturing capabilities span multiple global locations, and it distributes products through pharmaceutical wholesale distributors and direct-to-consumer channels.